anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Sequoia Pitch

Arc collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 43,093
Current window 19,861-19,890
Pages 1,437
Rows per page 30
Arc: Sequoia Pitchclear collectionreset all
18 30 60

Arc

19,861-19,890 of 43,093

filter-aware
17
AbCellera | Results Presentation Deck | 17 slidesAbCellera | Results Presentation Deck | 17 slides · AbCellera
Conference presentation Investor relations Beat · Closing Ask1 hit
08
AN2 Therapeutics | Investor Presentation Deck | 25 slidesAN2 Therapeutics | Investor Presentation Deck | 25 slides · AN2 Therapeutics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
09
Uses a nested Venn/funnel diagram to illustrate market segmentation.AN2 Therapeutics | Investor Presentation Deck | 25 slides · AN2 Therapeutics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
10
The slide uses a two-part table structure to contrast standard care with refractory care, emphasizing toxicity and lack of FDA approval for many agents.AN2 Therapeutics | Investor Presentation Deck | 25 slides · AN2 Therapeutics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
12
Scientific illustration showing molecular binding interaction.AN2 Therapeutics | Investor Presentation Deck | 25 slides · AN2 Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
13
EBO = Epetraborole; MAC = Mycobacterium avium complex; MIC = Minimum Inhibitory Concentration.AN2 Therapeutics | Investor Presentation Deck | 25 slides · AN2 Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
15
The charts demonstrate dose-dependent efficacy and synergy between EBO and SoC.AN2 Therapeutics | Investor Presentation Deck | 25 slides · AN2 Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
16
Includes a timeline diagram of the study design and bulleted clinical outcomes.AN2 Therapeutics | Investor Presentation Deck | 25 slides · AN2 Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
17
The slide highlights the therapeutic potential of the drug by showing superior accumulation at the site of infection.AN2 Therapeutics | Investor Presentation Deck | 25 slides · AN2 Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
19
Uses a funnel-like diagram to represent market segments.AN2 Therapeutics | Investor Presentation Deck | 25 slides · AN2 Therapeutics
Pitch deck Investor relations Beat · Business Model1 hit
20
The table uses checkmarks and X marks to denote performance against specific clinical criteria.AN2 Therapeutics | Investor Presentation Deck | 25 slides · AN2 Therapeutics
Pitch deck Investor relations Beat · Business Model1 hit
21
QIDP = Qualified Infectious Disease Product DesignationAN2 Therapeutics | Investor Presentation Deck | 25 slides · AN2 Therapeutics
Pitch deck Investor relations Beat · Business Model1 hit
22
The timeline shows clinical trial phases (Chronic Tox, Phase 1b, Ph 2/3 TR-MAC, Ph 1 Japan, Ph 2/3 Topline Data).AN2 Therapeutics | Investor Presentation Deck | 25 slides · AN2 Therapeutics
Pitch deck Investor relations Beat · Business Model1 hit
05
Includes headshots of four key executives and highlights of governance policies.Apollo Global Management | Investor Presentation Deck | 37 slides · Apollo Global Management
Pitch deck Investor relations Beat · Team1 hit
06
Uses a numbered list presentation to highlight key competitive advantages.Apollo Global Management | Investor Presentation Deck | 37 slides · Apollo Global Management
Pitch deck Investor relations Beat · Team1 hit
07
Uses a before-after framing to justify the shift toward alternative assets.Apollo Global Management | Investor Presentation Deck | 37 slides · Apollo Global Management
Pitch deck Investor relations Beat · Problem1 hit
10
Uses a custom risk-return scatter plot framework with categorical background shading.Apollo Global Management | Investor Presentation Deck | 37 slides · Apollo Global Management
Pitch deck Investor relations Beat · Solution1 hit
01
Slide 1
Bausch Health Companies | Results Presentation Deck | 50 slidesBausch Health Companies | Results Presentation Deck | 50 slides · Bausch Health
Conference presentation Investor relations Beat · Problem1 hit
02
Bausch Health Companies | Results Presentation Deck | 50 slidesBausch Health Companies | Results Presentation Deck | 50 slides · Bausch Health
Conference presentation Investor relations Beat · Problem1 hit
03
Standard corporate financial disclosure slide.Bausch Health Companies | Results Presentation Deck | 50 slides · Bausch Health
Conference presentation Investor relations Beat · Problem1 hit
04
Bausch Health Companies | Results Presentation Deck | 50 slidesBausch Health Companies | Results Presentation Deck | 50 slides · Bausch Health
Conference presentation Investor relations Beat · Problem1 hit
08
The slide uses a mix of bar charts and donut charts to visualize revenue composition and growth metrics.Bausch Health Companies | Results Presentation Deck | 50 slides · Bausch Health
Conference presentation Investor relations Beat · Financials1 hit
09
Unconsolidated revenue change vs 2Q21, in millions USD.Bausch Health Companies | Results Presentation Deck | 50 slides · Bausch Health
Conference presentation Investor relations Beat · Financials1 hit
10
The slide uses a 2x2 grid layout to present segment-specific financial performance and qualitative drivers.Bausch Health Companies | Results Presentation Deck | 50 slides · Bausch Health
Conference presentation Investor relations Beat · Financials1 hit
11
The slide uses a combination of bar charts for total revenue and donut charts for segment composition.Bausch Health Companies | Results Presentation Deck | 50 slides · Bausch Health
Conference presentation Investor relations Beat · Financials1 hit
12
The table is split into two main blocks: 2Q22 performance and YTD performance, with sub-totals for Bausch Pharma + Solta, Bausch+Lomb, and Total Bausch Health.Bausch Health Companies | Results Presentation Deck | 50 slides · Bausch Health
Conference presentation Investor relations Beat · Financials1 hit
13
Bausch Health Companies | Results Presentation Deck | 50 slidesBausch Health Companies | Results Presentation Deck | 50 slides · Bausch Health
Conference presentation Investor relations Beat · Financials1 hit
14
Includes footnotes regarding non-GAAP measures, share counts, and exclusions.Bausch Health Companies | Results Presentation Deck | 50 slides · Bausch Health
Conference presentation Investor relations Beat · Financials1 hit
17
Bausch Health Companies | Results Presentation Deck | 50 slidesBausch Health Companies | Results Presentation Deck | 50 slides · Bausch Health
Conference presentation Investor relations Beat · SolutionLoop · Why Now1 hit
18
The slide uses a bridge/waterfall structure to reconcile financial guidance.Bausch Health Companies | Results Presentation Deck | 50 slides · Bausch Health
Conference presentation Investor relations Beat · SolutionLoop · Why Now1 hit